Willis, Mark <br/><br/>
An observational study of alemtuzumab following fingolimod for multiple sclerosis.  [electronic resource] 

 -  Neurology(R) neuroimmunology & neuroinflammation  Mar 2017 
 - e320 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2332-7812 
<br/><br/><label>Standard No.: </label>10.1212/NXI.0000000000000320  doi